Drug intelligence / Profile preview

Diamel + insulin

Development stage
Unknown
Lead developer
Catalysis
Modality
Peptides, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Subcutaneous
01

Overview

Diamel + insulin refers to the co-administration of the multi-component dietary supplement Diamel with exogenous insulin for the management of diabetes mellitus. Diamel, developed by Catalysis S.L., is a nutraceutical formulation containing a blend of antioxidants, amino acids (such as arginine and glycine), vitamins, and minerals (including zinc) designed to reduce oxidative stress and improve metabolic parameters. When used as an adjuvant to insulin therapy, Diamel aims to enhance glycemic control, potentially reducing the required insulin dose and mitigating long-term complications associated with chronic hyperglycemia. The supplement components support insulin sensitivity and pancreatic function, while its antioxidant profile addresses the inflammatory state characteristic of diabetes.

Other names
Diamel and insulin therapy
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Diamel + insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diamel + insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call